Drug Trial Radar · NCT07575672
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,832
Planned (sponsor's estimate)
Start
Oct 9, 2026
Primary completion
Dec 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, double-blind, randomized, placebo-controlled trial. The purpose is to evaluate whether treatment with finerenone in patients with symptomatic severe aortic stenosis undergoing TAVI, and heart failure with LVEF ≥40% is associated with a reduction in the composite endpoint of all-cause mortality or worsening of heart failure. Participants are patients with symptomatic aortic stenosis undergoing TAVI and heart failure with LVEF≥40%. Eligible patients will be randomly assigned in a 1:1 ratio to either the finerenone group or the placebo group. Patients meeting all inclusion criteria and not any exclusion criteria will be invited to participate before discharge. All enrolled patients will consecutively receive treatment, during which serum potassium and estimated glomerular filtration rate will be closely monitored. Follow-up will be conducted at 30 days, 12 months at clinic, and 3 months, 6 months, 9 months and every 6 months after 12 months of enrollment online or via telephone (at clinic if necessary). The final visit will be conducted for all enrolled patients at the end of the study.
Conditions
- HFpEF - Heart Failure With Preserved Ejection Fraction
- TAVI(Transcatheter Aortic Valve Implantation)
- Finerenone
Interventions
FinerenoneDrug
Oral treatment with finerenone daily: * For participants with an eGFR ≤60 mL/min/1.73 m2: Starting dose is 10 mg OD and target dose 20 mg OD. * For participants with an eGFR \>60 mL/min/1.73 m2: Starting dose is 20 mg OD and target dose 40 mg OD.
PlaceboDrug
Oral treatment with placebo daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- A composite of all-cause mortality or worsening of heart failure (hospitalization for HF or urgent HF visit), any of the first occurrence during the follow-up.Time frame: at least 12 months
Locations
61 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China · Not yet recruiting
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China · Not yet recruiting
Affiliated Beijing Chaoyang Hospital of Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Anzhen Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
Chinese People's Liberation Army General Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China · Not yet recruiting
Peking University Third Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Army Medical Center of the People's Liberation Army
Chongqing, Chongqing Municipality, China · Not yet recruiting
The First Affiliated Hospital of Army Medical University
Chongqing, Chongqing Municipality, China · Not yet recruiting
The Second Affiliated Hospital of Army Medical University
Chongqing, Chongqing Municipality, China · Not yet recruiting
Fujian Medical University Union Hospital
Fuzhou, Fujian, China · Not yet recruiting
Fuzhou University Affiliated Provincial Hospital
Fuzhou, Fujian, China · Not yet recruiting
The First Hospital of Lanzhou University
Lanzhou, Gansu, China · Not yet recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China · Not yet recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
Fuwai Huazhong Cardiovascular Hospital
Zhengzhou, Henan, China · Not yet recruiting
Henan Chest Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Zhengzhou No.7 People's Hospital
Zhengzhou, Henan, China · Not yet recruiting
Renmin Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Nanjing First Hospital
Nanjing, Jiangsu, China · Not yet recruiting
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China · Not yet recruiting
Liaoning Provincial People's Hospital
Shenyang, Liaoning, China · Not yet recruiting
People's Liberation Army Northern Theater Command General Hospital
Shenyang, Liaoning, China · Not yet recruiting
The First Hospital of China Medical University
Shenyang, Liaoning, China · Not yet recruiting
The First Affiliated Hospital of Air Force Medical University
Xi'an, Shaanxi, China · Not yet recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China · Not yet recruiting
The Second Affiliated Hospital of Air Force Medical University
Xi'an, Shaanxi, China · Not yet recruiting
Qilu Hospital of Shandong University
Jinan, Shandong, China · Not yet recruiting
Shandong Provincial Qianfoshan Hospital
Jinan, Shandong, China · Not yet recruiting
Qingdao Municipal Hospital
Qingdao, Shandong, China · Not yet recruiting
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.